Top Abstract Purchase Related
Home
>
Node
>
Subnode

Subclasses of IgG (IgG1-IgG4) in children during specific immunotherapy

Trofimowicz, A.; Stasiak-Barmuta, A.; Tobolczyk, J.; Botulińska, E.

Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 5(30): 354-356

1998

ISSN/ISBN: 1426-9686
PMID: 10101523
Document Number: 495643
The aim of this study was determination of IgG subclasses: IgG1, IgG2, IgG3 and IgG4 in children with atopic bronchial asthma and allergy rhinitis during long-term specific immunotherapy. The results showed in crease of IgG1 at first and next IgG4 subclasses. In our opinion it's a positive reaction of specific immunotherapy. Decrease of IgG2 and in less degree of IgG3 must be very carefully observation and analyse general in children with recurrent infections in the respiratory tract during specific immunotherapy.

Document emailed within 1 workday
Secure & encrypted payments

Drössler, K.; Hädge, D.; Ambrosius, H. 1982: Structural and functional characteristics of IgG1- and IgG2-antibody subclasses in the guinea pig. 2. Production and testing of specific antisera against IgG1 and IgG2-antibody subclasses and against Fc-, Fc'- and Fab-papain fragments of IgG2-antibodies in guinea pigs Acta Biologica et Medica Germanica 41(4): 393-400
De Castro, G.; Zicari, A.M.; Indinnimeo, L.; Tancredi, G.; di Coste, A.; Occasi, F.; Castagna, G.; Giancane, G.; Duse, M. 2013: Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life European Review for Medical and Pharmacological Sciences 17(16): 2225-2231
Živković, Z.; Djurić-Filipović, I.; Živanović, Sžana. 2016: Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis Srpski Arhiv Za Celokupno Lekarstvo 144(5-6): 345-350
Wang, J.Y.; Lei, H.Y.; Hsieh, K.H. 1992: The change of allergen-specific IgG subclass antibodies during immunotherapy in mite-sensitive asthmatic children Asian Pacific Journal of Allergy and Immunology 10(1): 11-18
Moncayo Coello, C.V.; Rosas Vargas, M.A.; del Rio Navarro, B.E.; Lerma Ortiz, L.; Velázquez Armenta, Y.; Sienra Monge, J.J.é 2003: Quality of life in children with allergic rhinitis before and after being treated with specific immunotherapy (cases and controls) Revista Alergia Mexico 50(5): 170-175
Boznański, A.; Willak-Janc, E.; Domanasiewicz, M.; Pirogowicz, I.; Widerska, A. 1996: Evaluation of soluble components of receptors with weak affinity for IgE (sCD23) in children with pollinosis given specific immunotherapy Pneumonologia i Alergologia Polska 64(7-8): 386-391
García, B.E.; Sanz, M.L.; Diéguez, I.; de las Marinas, M.D.; Oehling, A. 1992: Specific IgG subclasses in pollinosis Journal of Investigational Allergology and Clinical Immunology 2(6): 300-306
Silny, W.; Czarnecka-Operacz, M.; Silny, P.ł 2005: Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score Wiadomosci Lekarskie 58(1-2): 47-55
Cantani, A.; Arcese, G.; Lucenti, P.; Gagliesi, D.; Bartolucci, M. 1997: A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma Journal of Investigational Allergology and Clinical Immunology 7(2): 90-97
Rogala, B.; Glück, J. 1999: Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy Journal of Investigational Allergology and Clinical Immunology 9(3): 183-189
Rogala, B.; Jarzab, J.; Rymarczyk, B.; Tłuczykont, B. 2004: Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy Wiadomosci Lekarskie 57(3-4): 123-130
Widhe, M.; Ekerfelt, C.; Forsberg, P.; Bergström, S.; Ernerudh, J. 1998: IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease Scandinavian Journal of Immunology 47(6): 575-581
Taniguchi, M.; Rebellato, L.M.; Briley, K.P.; Haisch, C.E.; Bolin, P.; Banuelos, N.; Hopfield, J.; Terasaki, P.I.; Everly, M.J. 2015: Risk Stratification of Human Leukocyte Antigen Class II Donor Specific Antibody Positive Patients by Immunoglobulin G Subclasses Clinical Transplants 31: 293-301
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399
Fanning, E.; Westphal, K.H.; Brauer, D.; Cörlin, D. 1982: Subclasses of simian virus 40 large T antigen: differential binding of two subclasses of T antigen from productively infected cells to viral and cellular DNA EMBO Journal 1(9): 1023-1028
Cheung, N.K.; Medof, M.E.; Munn, D. 1988: Immunotherapy with GD2 specific monoclonal antibodies Progress in Clinical and Biological Research 271: 619-632
Breborowicz, A. 2003: Practical aspects of specific immunotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(84): 692-694
Romański, B. 1984: Specific immunotherapy of atopic diseases Polski Tygodnik Lekarski 39(31): 1021-1026
Musarra, A.; Bilò, M.B.; Bonini, S.; Canonica, G.W.; Senna, G.E. 2013: Consensus on allergen specific immunotherapy European Annals of Allergy and Clinical Immunology 45(Suppl 3): 1-49
Fradkin, V.A.; Roshal', N.I.; Goriachkina, L.A.; Nikonorova, M.V.; Astaf'eva, N.G.; Luss, L.V.; Raĭkis, V.N. 1993: The use of Russian allergoids for the specific immunotherapy of pollinosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 101-105